Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

CAPR stock hub

Capricor Therapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CAPRis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.8B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

CAPR

In the news

Latest news · CAPR

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-46.6

P25 -105.6P50 -46.5P75 -3.1

ROIC-28.9

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CAPR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

188

Groups with data

Currency

USD

Showing 188 of 188 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001133869
Company name	Capricor Therapeutics, Inc.
Country	United States
Country code	US
Cusip	14070B309
Employees	231
Employees Change	71%
Employees Change Percent	44.38
Enterprise value	$1.5B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US14070B3096
Last refreshed	2026-05-10
Market cap	$1.8B
Market cap category	Small-Cap
Price	$30.38
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	CAPR
Website	https://www.capricor.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-5.98%
FCF yield	-4.64%
P/B ratio	5.7x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-84.5M
Net Income	$-105M
Net Income Growth Years	0%
Profit Per Employee	$-454,736
ROA	-25.68
Roa5y	-30.32
ROCE	-33.78
ROE	-46.56
Roe5y	-85.21
ROIC	-28.93

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-1.75%
Cagr1y	341.38%
Cagr3y	97.86%
Cagr5y	54.34%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$355.9M
Cash	$318.1M
Current Assets	$322.9M
Current Liabilities	$35.8M
Debt	$14.5M
Debt Equity	$0.05
Equity	$305.8M
Interest Coverage	-35.51
Liabilities	$50.2M
Long Term Assets	$33M
Long Term Liabilities	$14.3M
Net Cash	$303.6M
Net Cash By Market Cap	$17.28
Net Cash Growth	102.32%
Net Debt Equity	$-0.99
Tangible Book Value	$305.8M
Tangible Book Value Per Share	$5.33
WACC	6.99

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	9.01
Net Working Capital	$-30.8M
Quick ratio	8.88
Working Capital	$287.1M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-31.97%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-16.19%
1Y total return	340.93%
200-day SMA	18.48
3Y total return	675%
50-day SMA	31.58
50-day SMA vs 200-day SMA	50over200
5Y total return	775.5%
All Time High	171.5
All Time High Change	-82.29%
All Time High Date	2014-01-22
All Time Low	0.88
All Time Low Change	3,352.27%
All Time Low Date	2020-03-12
ATR	2.32
Beta	0.48
Beta1y	2.62
Beta2y	2.2
Ch YTD	5.27
High	31.28
High52	40.37
High52 Date	2025-12-03
High52ch	-24.75%
Low	28.45
Low52	4.3
Low52 Date	2025-11-25
Low52ch	606.51%
Ma50ch	-3.8%
Premarket Change Percent	-13.08
Premarket Price	$29.5
Premarket Volume	79,031
Price vs 200-day SMA	64.43%
RSI	42.71
RSI Monthly	65.3
RSI Weekly	60.54
Sharpe ratio	1.09x
Sortino ratio	5.74
Total Return	-31.97%
Tr YTD	5.27
Tr1m	-4.97%
Tr1w	-1.71%
Tr3m	22.9%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	8
Analyst Count Top	4
Analyst Price Target Top	$40
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.54
Earnings Revenue Estimate	25,200,000x
Operating Income	$-108.1M
Price target	$44.63
Price Target Change	$46.91
Price Target Change Top	$31.67

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	48,885,171%
Float Percent	84.52%
Shares Insiders	1.02%
Shares Institutions	45.14%
Shares Out	57,840,102
Shares Qo Q	6.86%
Shares Yo Y	31.97%
Short Float	20.53%
Short Ratio	7.73
Short Shares	17.35

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-98.8M
Average Volume	1,070,451.1x
Bv Per Share	5.33
CAPEX	$-11.7M
Ch10y	-16.19
Ch1m	-4.97
Ch1w	-1.71
Ch1y	340.9
Ch3m	22.9
Ch3y	675
Ch5y	775.5
Ch6m	412.3
Change	-10.49%
Change From Open	2.98
Close	33.94
Days Gap	-13.08
Depreciation Amortization	1,889,041
Dollar Volume	112,640,594.4
Earnings Date	2026-05-12
Earnings Time	amc
EBIT	$-108.1M
EBITDA	$-106.3M
EPS	$-2.26
F Score	2
FCF	$-81.5M
FCF EV Yield	-5.61x
FCF Per Share	$-1.41
Financing CF	248,892,296
Fiscal Year End	December
Founded	2,005
Income Tax	$1,600
Investing CF	97,479,281
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-12
Last Report Date	2025-12-31
Last Split Date	2019-06-05
Last Split Type	Reverse
Last10k Filing Date	2026-03-17
Ma150	22.29
Ma150ch	36.27%
Ma20	33.92
Ma20ch	-10.44%
Net CF	276,560,316
Next Earnings Date	2026-05-12
Open	29.5
Optionable	Yes
Position In Range	68.2
Post Close	30.38
Postmarket Change Percent	-0.59
Postmarket Price	$30.2
Ppne	31,850,058
Pre Close	33.94
Price Date	2026-05-08
Ptbv Ratio	5.75
Relative Volume	3.46x
Share Based Comp	17,225,260
Tr6m	412.31%
Us State	California
Volume	3,707,722

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CAPR pay a dividend?

Capital-return profile for this ticker.

Performance

CAPR stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CAPR?

Insider, institutional, and short-interest positioning.

Institutional ownership

+45.1%

Float: +84.5% of shares outstanding

Insider ownership

+1.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

CAPR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.7

Neutral momentum band

Price vs 200-day MA

+64.4%

50/200-day relationship not available

Beta (5Y)

0.48

Less volatile than the market

Sharpe ratio

1.09

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CAPR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current CAPR stock rating?

Capricor Therapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CAPR analysis?

The full report lives at /stocks/CAPR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for CAPR?

The latest report frames CAPR around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the CAPR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.